FindTrial
Sign In

Effect of fresh frozen plasma infusion on coagulation during ECMO in children

Effect of fresh frozen plasma infusion on coagulation during ECMO in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031758
Enrollment
Unknown
Registered
2020-04-09
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal membrane oxygenation

Interventions

AT III80%:Infusion of fresh frozen plasma every day to keep at III always > 80%

Sponsors

The 7th Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Children receiving ECMO from birth to the age of 14

Exclusion criteria

Exclusion criteria: 1. ECMO treatment time less than 24 hours; 2. No plasma transfusion during ECMO treatment; 3. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
ATIII;ACT/APTT/anti-Xa;Heparin dosage;haemorrhage/thrombotic events;—

Countries

China

Contacts

Public ContactZhichun Feng

The 7th Medical Center of PLA

zhjfengzc@126.com+86 13321154215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026